Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 0.26% institutional investors, and 99.74% retail investors. LUX IM Global Medtech HX is the top mutual fund, with 0.04% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akari Therapeutics	0.26%	-	99.74%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2023	2	100.00%	164,031	-7.89%	-	322.97%	1	-	1	-
Sep 30, 2023	1	-93.75%	178,091	-98.23%	-	0.11%	-	-100.00%	1	-50.00%
Jun 30, 2023	16	45.45%	10,076,550	-0.44%	16	6.14%	6	100.00%	2	-
Mar 31, 2023	11	-26.67%	10,120,691	13.43%	16	7.94%	3	-50.00%	-	-100.00%
Dec 31, 2022	15	15.38%	8,922,318	-11.78%	14	4.92%	6	-	3	200.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
LUX IM Global Medtech HX	10.26K	0.04%	-
Fidelity Nasdaq Composite Index	1.51K	0.01%	-
RiverNorth Marketplace Lending Corp	1.10K	0.00%	1.10K
RiverNorth Opportunities	509.00	0.00%	509.00

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 0.26%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 68.48%, which Akari Therapeutics falls below.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is the top mutual fund holder of Akari Therapeutics shares?

LUX IM Global Medtech HX is the top mutual fund holder of Akari Therapeutics shares, with 0.04% of its total shares outstanding invested in 10.26K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools